PNC Financial Services Group Inc. Raises Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

PNC Financial Services Group Inc. raised its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,276 shares of the company’s stock after buying an additional 296 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Prestige Consumer Healthcare were worth $412,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of PBH. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the fourth quarter worth about $27,000. GAMMA Investing LLC raised its holdings in Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares during the last quarter. KBC Group NV boosted its stake in Prestige Consumer Healthcare by 28.3% during the 4th quarter. KBC Group NV now owns 2,048 shares of the company’s stock valued at $160,000 after purchasing an additional 452 shares during the last quarter. Blue Trust Inc. boosted its stake in Prestige Consumer Healthcare by 24.8% during the 4th quarter. Blue Trust Inc. now owns 2,190 shares of the company’s stock valued at $158,000 after purchasing an additional 435 shares during the last quarter. Finally, Longboard Asset Management LP purchased a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth $201,000. Institutional investors own 99.95% of the company’s stock.

Insider Transactions at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares of the company’s stock, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Canaccord Genuity Group upped their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Tuesday. Oppenheimer boosted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Finally, DA Davidson lifted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $92.60.

Prestige Consumer Healthcare Stock Performance

PBH opened at $84.22 on Friday. The company has a market cap of $4.17 billion, a P/E ratio of 19.72, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The firm’s 50-day moving average price is $82.25 and its 200-day moving average price is $78.53. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.